×
We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd., | 2.21 | -0.31 | NA | -1.25 | 0 | |
| JAGSONPAL PHARMACEUTICALS LTD. | 774.92 | 125.74 | 744.65 | 1.87 | 1,432 | 33.6 |
| KMC SPECIALITY HOSPITALS (INDI | 673.53 | 75.35 | 665.53 | 0.46 | 1080 | 46.0 |
| LINCOLN PHARMACEUTICALS LTD. | 1693.38 | 276.75 | 1540.67 | 13.82 | 1076 | 12.5 |
Jagsonpal Pharmaceuticals Limited,, with Security Code 507789, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2025 | Jun 2025 | Sep 2025 | Sep 2025 | Sep 2025 | Sep 2025 | Sep 2025 | Sep 2025 | Sep 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 58.6 | 75.6 | 74.5 | 74.5 | 74.5 | 74.5 | 74.5 | 74.5 | 74.5 | 74.5 |
| Expenses | 49.8 | 61.4 | 58.0 | 58.0 | 58.0 | 58.0 | 58.0 | 58.0 | 58.0 | 58.0 |
| Operating Profit | 8.7 | 14.2 | 16.4 | 16.4 | 16.4 | 16.4 | 16.4 | 16.4 | 16.4 | 16.4 |
| OPM % | 14.9% | 18.8% | 22.07% | 22.07% | 22.07% | 22.07% | 22.07% | 22.07% | 22.07% | 22.07% |
| Other Income | 2.6 | 2.8 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 |
| Interest | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
| Depreciation | 2.3 | 2.4 | 2.4 | 2.4 | 2.4 | 2.4 | 2.4 | 2.4 | 2.4 | 2.4 |
| Profit before tax | 8.9 | 14.4 | 16.8 | 16.8 | 16.8 | 16.8 | 16.8 | 16.8 | 16.8 | 16.8 |
| Tax % | -24.1% | 25.2% | 25.2% | 25.2% | 25.2% | 25.2% | 25.2% | 25.2% | 25.2% | -25.2% |
| Net Profit | 6.6 | 10.8 | 12.6 | 12.6 | 12.6 | 12.6 | 12.6 | 12.6 | 12.6 | 12.6 |
| EPS in Rs | 0 | 1.58 | 1.87 | 1.87 | 1.87 | 1.87 | 1.87 | 1.87 | 1.87 | 0 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 11% |
| 3 Years: | 7% |
| TTM: | 29% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 42% |
| 5 Years: | 38% |
| 3 Years: | 29% |
| TTM: | 77% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 35% |
| 5 Years: | 85% |
| 3 Years: | 20% |
| 1 Year: | 59% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|